Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
1.460
+0.040 (2.82%)
At close: Aug 14, 2025, 4:00 PM
1.410
-0.050 (-3.42%)
After-hours: Aug 14, 2025, 4:44 PM EDT
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $10.43 million as of August 14, 2025. Its market cap has decreased by -45.38% in one year.
Market Cap
10.43M
Enterprise Value
12.62M
1-Year Change
-45.38%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $10.43M, a decrease of -97.49%. That is a compound annual growth rate of -42.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 10.14M | -35.41% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | 84.01M | -81.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 568.89B |
| Johnson & Johnson | 416.26B |
| AbbVie | 349.78B |
| UnitedHealth Group | 236.07B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.61B |
| Novo Nordisk | 222.88B |